Epitropoulos, A. T., Daya, S. M., Matossian, C., Kabat, A. G., Blemker, G., Striffler, K., . . . Gibson, A. (2022). OC-01 (Varenicline Solution) Nasal Spray Demonstrates Consistency of Effect Regardless of Age, Race, Ethnicity, and Artificial Tear Use. Clinical Ophthalmology, 16, 3405. https://doi.org/10.2147/OPTH.S383091
Chicago Style (17th ed.) CitationEpitropoulos, Alice T., Sheraz M. Daya, Cynthia Matossian, Alan G. Kabat, Gretchen Blemker, Kristen Striffler, Laura Hendrix, Marian Macsai, and Andrea Gibson. "OC-01 (Varenicline Solution) Nasal Spray Demonstrates Consistency of Effect Regardless of Age, Race, Ethnicity, and Artificial Tear Use." Clinical Ophthalmology 16 (2022): 3405. https://doi.org/10.2147/OPTH.S383091.
MLA (9th ed.) CitationEpitropoulos, Alice T., et al. "OC-01 (Varenicline Solution) Nasal Spray Demonstrates Consistency of Effect Regardless of Age, Race, Ethnicity, and Artificial Tear Use." Clinical Ophthalmology, vol. 16, 2022, p. 3405, https://doi.org/10.2147/OPTH.S383091.